Cdt equity inc.CDT.US Overview

US StockHealthcare

(No presentation for CDT)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

CDT Overall Performance

CDT AI Analysis & Strategy

CDT Recent Performance

-10.00%

Cdt equity inc.

0.81%

Avg of Sector

-1.14%

S&P500

CDT PowerScanner

CDT Key Information

CDT Valuation Metrics

CDT Earnings Table

CDT Profile

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.